Cointime

ARTHEx Biotech

company

About

AntagomiR oligonucleotides to treat Myotonic Dystrophy patients.

  • 1 - 10

Highlights

Total Funding Amount
€2.50M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
€2.50M
Industries
Biotechnology
Founded date
Jan 1, 2019
Number Of Employee
1 - 10
Operating Status
Active

ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing antisense RNA treatments against genetic diseases. Our team has a strong background on drug discovery and microRNAs involvement in neuromuscular diseases. We are supported by world-renowned scientific and clinical advisors that will facilitate the successful development of our products.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€2.50M
ARTHEx Biotech has raised a total of €2.50M in funding over 2 rounds. Their latest funding was raised on Oct 14, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 14, 2022 Grant €2.50M 1 European Innovation Council — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
ARTHEx Biotech is funded by 1 investors. European Innovation Council are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Grant
Cointime
เนื้อหา
บริษัท